HS-20118

DRUG3 trials

Sponsors

Jiangsu Hansoh Pharmaceutical Co., Ltd.

Conditions

Moderate to Severe Plaque PsoriasisPsoriasis

Phase 1

Evaluate the Safety and Pharmacokinetics/Pharmacodynamics of HS-20118

RecruitingNCT06846710

Jiangsu Hansoh Pharmaceutical Co., Ltd.Psoriasis

Start: 2025-05-02End: 2027-02-28Target: 132Updated: 2025-08-07

Evaluate the Safety and Pharmacokinetics/Pharmacodynamics and Food Effect of HS-20118

RecruitingNCT07033234

Jiangsu Hansoh Pharmaceutical Co., Ltd.Psoriasis

Start: 2025-05-16End: 2026-03-31Target: 142Updated: 2025-06-24

Phase 2

A Phase 2 Study of HS-20118 to Evaluate the Efficacy and Safety in Participant With Moderate-to-Severe Plaque Psoriasis

Not yet recruitingNCT07765628

Jiangsu Hansoh Pharmaceutical Co., Ltd.Moderate to Severe Plaque Psoriasis

Start: 2026-08-06End: 2027-07-10Target: 120Updated: 2026-08-14